We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site, or closing this box, you consent to our use of cookies.

X

Latest Post

August 21, 2018

NASH: The Silent Liver Disease

With the prevalence of Non-alcoholic Steatohepatitis (NASH) rapidly increasing globally, West is working with its pharmaceutical partners to support their development of new injectable treatments for this serious liver condition. However, there are many challenges associated with trying to bring new treatments to market.</br>
Aileen Kinsella

Aileen Kinsella

Director, Segment Marketing, Pharma

Previous Posts
Round Industrial Thermometer

September 22, 2017

Regulating the Cold Chain

Shari Krusniak

Shari Krusniak

Sr. Manager, Marketing, Contract Manufacturing

Cold Temperature Thermometer

August 24, 2017

What is Cold?

Shari Krusniak

Shari Krusniak

Manager, Marketing, Contract Manufacturing

A patient with diabetes injecting themselves using an auto-injector

July 31, 2017

Growth in GLP-1 Drugs May Offer Improved Outcomes to People with Type II Diabetes

Aileen Kinsella

Aileen Kinsella

Director, Segment Marketing, Pharma

Load more